SCIG in Focus: Equipping Clinicians for CIDP Care - January 2026

Recorded On: 01/15/2026

Clinical Edge: Standardized Supplies for SCIG Patients

This session will provide professionals with an overview of standardized supplies commonly used with SCIG patients.

  1. Describe patient-specific characteristics used to guide product selection and, therefore, also SCIG supply selection.
  2. Discuss patient assessment findings and how to integrate them into SCIG administration practices.
  3. Review the importance of education and strategies for training.
  4. Recognize the importance of multi-disciplinary collaboration, communication, and shared decision-making to optimize SCIG patient outcomes.

Clinical Connect: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

This session will provide professionals with an overview of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and the infusion therapies prescribed for treatment.

  1. Describe the pathophysiology, typical clinical features, and initial diagnostic workup for CIDP, and outline treatment options.
  2. Examine the current efficacy, safety, dosing, and administration of therapies for chronic inflammatory demyelinating polyneuropathy (CIDP).
  3. Analyze best practices for the formulation transition of intravenous to subcutaneous immunoglobulin (IVIG to SCIG) among patients with CIDP.
  4. Identify the role of specialty pharmacists in monitoring therapy, optimizing the management of patients, and how collaborating with the interdisciplinary team fosters continuity and safety in patient care and outcomes. 

Clinical Edge: A Case Study: Examining a Patient with CIDP on SCIG

This session will provide professionals with an immersive case study experience on a CIDP patient receiving SCIG.

  1. Explain which CIDP patients are ideal candidates for SCIG therapy and important considerations to evaluate when switching from IVIG to SCIG therapy.
  2. Discuss current SCIG efficacy and safety information, dosing, and administration for CIDP and how real-world data may differ.
  3. Improve patient outcomes in CIDP by identifying risk factors and addressing challenges with SCIG therapy.

NHIA General CE Information

Leslie Myers, PharmD, IgCP

Integrated Clinical Manager

CSI Pharmacy

Dr. Leslie Myers, PharmD, IgCP has a wealth of experience in the field of immunoglobulin therapies with a strong background as a clinical pharmacist within the realm of specialty home infusion. Her dedication to enhance patients’ lives requiring clinical intervention through specialty medications aligns perfectly with the culture at CSI. She earned her Doctor of Pharmacy degree from Campbell University in 2008, graduating summa cum laude. Leslie was the founding president of the Women’s Integration Network within AMCP and also enjoys working with Immunoglobulin National Society (IgNS) through multiple committee roles and development of national Ig Therapy Standards of Practice.

NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

Leslie Myers has no relevant financial relationships with ineligible companies to disclose.

Key:

Complete
Failed
Available
Locked
Clinical Edge: Standardized Supplies for SCIG Patients
Clinical Edge: Standardized Supplies for SCIG Patients - On Demand
Recorded 11/10/2025  |  15 minutes
Recorded 11/10/2025  |  15 minutes
You must register to access.
Post Education Survey - On Demand
8 Questions
8 Questions Clinical Edge: Standardized Supplies for SCIG Patients NHIA On Demand Webinar - 0.25 CE
You must register to access.
Required to Claim On Demand CE
Up to 0.25 medical credits available  |  Certificate available
Up to 0.25 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** ________________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Please note that the certificates printed from this platform are invalid as proof of continuing education (CE). For official documentation of CE credits, please print a paper statement of credit from your NABP e-profile.
You must register to access.
Clinical Connect: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical Connect: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - On Demand
Recorded 01/14/2026  |  30 minutes
Recorded 01/14/2026  |  30 minutes
You must register to access.
Post Education Survey - On Demand
8 Questions
8 Questions Clinical Connect: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NHIA On Demand Webinar, 0.50 CE
You must register to access.
Required to Claim On Demand CE
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** ________________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Please note that the certificates printed from this platform are invalid as proof of continuing education (CE). For official documentation of CE credits, please print a paper statement of credit from your NABP e-profile.
You must register to access.
Clinical Edge: A Case Study: Examining a Patient with CIDP on SCIG
Clinical Edge: A Case Study: Examining a Patient with CIDP on SCIG - On Demand
Recorded 01/15/2026  |  15 minutes
Recorded 01/15/2026  |  15 minutes
You must register to access.
Post Education Survey - On Demand
8 Questions
8 Questions Clinical Edge: A Case Study: Examining a Patient with CIDP on SCIG NHIA On Demand Webinar
You must register to access.
Required to Claim On Demand CE
Up to 0.25 medical credits available  |  Certificate available
Up to 0.25 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** ________________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Please note that the certificates printed from this platform are invalid as proof of continuing education (CE). For official documentation of CE credits, please print a paper statement of credit from your NABP e-profile.
You must register to access.